We’ve Got Our Eye on the ‘Sky’ as a New Position
Here’s our trading plan for the $10,000 Portfolio as we begin the week.
New Ocular Therapeutix Target Price Amid Support
The small-cap firm is likely to see defense by professional managers.
What Zipline’s Head-Turning $20 Billion Valuation Means for Our Drone Holding
Is this a positive or negative for Ondas? let’s discuss.
Buying More Rocket Lab After $1.9 Billion Acquisition Update
The aerospace firm announced a at-the-market share sale.
Our Small-Cap Holding Makes $205 Million Acquisition
Plus, we’re buying more shares of these two names.
Trimming 2 Disappointments, Eyeing 4 Buys
Here’s our trading plan for Friday and updates on key holdings.
Why I’m Adding to 3 Stocks on Weakness
Sometimes to push forward, you have to take a little pain with your trades as we will today in the $10K Portfolio.
We’re Cashing in on 3 Small-Cap Names as the Market Rallies
Some strange but true updates on our “$10K Portfolio” names.
Investors See Problems With Our Small-Cap Drone Name
Short interest is growing in Ondas as it prepares for increased defense spending.
Kevin Warsh Puts a Hurting on Our Small-Cap Portfolio
The Federal Reserve chair’s address hurt equities, including several of our names.